Nuvation Bio Inc. Earnings Dividend
Earnings Summary
Revenue | $31.69Mn |
Net Profits | $-62.84Mn |
Net Profit Margins | -198.31% |
Nuvation Bio Inc.’s revenue jumped 555.64% since last year same period to $31.69Mn in the Q2 2026. On a quarterly growth basis, Nuvation Bio Inc. has generated -61.93% fall in its revenue since last 3-months.
Nuvation Bio Inc.’s net profit fell -6.5% since last year same period to $-62.84Mn in the Q2 2026. On a quarterly growth basis, Nuvation Bio Inc. has generated -1264.35% fall in its net profits since last 3-months.
Nuvation Bio Inc.’s net profit margin jumped 83.76% since last year same period to -198.31% in the Q2 2026. On a quarterly growth basis, Nuvation Bio Inc. has generated -3158.24% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.15 |
EPS Estimate Current Year | -0.15 |
Nuvation Bio Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.15 - a -247.22% fall from last quarter’s estimates.
Nuvation Bio Inc.’s earning per share (EPS) estimates for the current year stand at -0.15.
Key Ratios
Earning Per Share (EPS) | -0.15 |
Nuvation Bio Inc.’s earning per share (EPS) jumped 11.76% since last year same period to -0.15 in the Q2 2026. This indicates that the Nuvation Bio Inc. has generated 11.76% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-05-04 | -0.04 | 0.01 | 123.15% |
2026-08-06 | -0.15 | -0.15 | 0% |
